These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1100953)

  • 1. A controlled clinical trial of continuous and intermittent rifampicin therapy during an initial three months period in lepromatous leprosy: final analysis.
    Pattyn SR; Rollier MT; Rollier R; Saerens EJ; Dockx P
    Lepr Rev; 1975 Jun; 46(2 Suppl):129-39. PubMed ID: 1100953
    [No Abstract]   [Full Text] [Related]  

  • 2. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
    Li WZ
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
    [No Abstract]   [Full Text] [Related]  

  • 5. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
    Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD; Tantiongco PR
    Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
    [No Abstract]   [Full Text] [Related]  

  • 7. A statistical analysis of two chemotherapy trials in lepromatous leprosy. II. Interactions among patient variables.
    Am J Trop Med Hyg; 1978 Sep; 27(5):1015-8. PubMed ID: 362951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin for lepromatous leprosy: nine years' experience.
    Waters MF; Rees RJ; Pearson JM; Laing AB; Helmy HS; Gelber RH
    Br Med J; 1978 Jan; 1(6106):133-6. PubMed ID: 339995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of treatment of leprosy patients in The Netherlands with daily rifampicin, dapsone and clofazimine.
    Leiker DL
    Lepr Rev; 1986; 57 Suppl 3():272-3. PubMed ID: 3573955
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined treatments consisting of rifampicin in periodic doses: the experience in Niger].
    Soga G; Blanc L; Alfa C; Grosset J; Xavier S
    Acta Leprol; 1986; 4(4):397-407. PubMed ID: 3296609
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 12. Multidrug therapy for leprosy in Trinidad and Tobago: a preliminary report.
    Keeler RF
    Lepr Rev; 1984 Dec; 55(4):391-6. PubMed ID: 6396477
    [No Abstract]   [Full Text] [Related]  

  • 13. Leprosy. Recognition and treatment.
    Ramos-e-Silva M; Rebello PF
    Am J Clin Dermatol; 2001; 2(4):203-11. PubMed ID: 11705247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy in leprosy.
    Gatti JC
    Lepr Rev; 1975 Jun; 46(2 Suppl):155-60. PubMed ID: 1100955
    [No Abstract]   [Full Text] [Related]  

  • 15. THELEP controlled clinical trials in lepromatous leprosy.
    Lepr Rev; 1983 Sep; 54(3):167-76. PubMed ID: 6355720
    [No Abstract]   [Full Text] [Related]  

  • 16. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-monthly rifampicin plus daily dapsone in initial treatment of lepromatous leprosy.
    Yawalkar SJ; McDougall AC; Languillon J; Ghosh S; Hajra SK; Opromolla DV; Tonello CJ
    Lancet; 1982 May; 1(8283):1199-202. PubMed ID: 6122970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of neuritis in borderline leprosy with rifampicin and corticosteroids--a pilot trial.
    Steenbergen GJ; Pfaltzgraff RE
    Lepr Rev; 1975 Jun; 46(2):115-8. PubMed ID: 1160473
    [No Abstract]   [Full Text] [Related]  

  • 19. Introductory rifampicin therapy in lepromatous leprosy: a six month follow-up study.
    Girdhar BK; Ramu G; Sreevatsa ; Desikan KV
    Lepr India; 1978 Jul; 50(3):363-70. PubMed ID: 359925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple drug therapy--a comparative study with 2 tier and 3 tier combination of rifampicin, clofazimine, DDS, INAH and thiacetazone in lepromatous cases.
    Kundu SK; Ghosh S; Hazra S; Chaudhury S
    Lepr India; 1981 Apr; 53(2):248-58. PubMed ID: 6166791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.